Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.
about
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsInterventions for preventing relapse and recurrence of a depressive disorder in children and adolescentsPsychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsThe Prevalence of Mental Disorders Among Children and Adolescents in the Child Welfare System: A Systematic Review and Meta-AnalysisPsychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and NutritionThe neural effects of psychotropic medications in children and adolescentsSystematic review of management for treatment-resistant depression in adolescentsEnhancing the developmental appropriateness of treatment for depression in youth: integrating the family in treatmentBehavioral and Psychiatric Phenotypes in 22q11.2 Deletion SyndromeTipepidine in adolescent patients with depression: a 4 week, open-label, preliminary studyComparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysisRegulation of emotional response in juvenile monkeys treated with fluoxetine: MAOA interactionsThe emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depressionAdolescent depressive disorders and family based interventions in the Family Options multicenter evaluation: study protocol for a randomized controlled trialEffective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.Antidepressants and suicide in adolescents and adults: a public health experiment with unintended consequences?Safety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder.Contextual socioeconomic status and mental health counseling use among US adolescents with depressionEarly prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder.Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.Transcranial Direct Current Stimulation: Considerations for Research in Adolescent Depression.Review: magnetic resonance spectroscopy studies of pediatric major depressive disorderEvidence for the management of adolescent depression.Phone-Based Interventions in Adolescent Psychiatry: A Perspective and Proof of Concept Pilot Study With a Focus on Depression and Autism.Developmental and psychosocial issues in cystic fibrosis.Depression and suicidal behavior in adolescents: a multi-informant and multi-methods approach to diagnostic classificationAssociation of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study.Primary care providers' initial treatment decisions and antidepressant prescribing for adolescent depressionConditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder?Prioritizing research to reduce youth suicide and suicidal behavior.Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence?Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.Sleep problems and suicide attempts among adolescents: a case-control studyOnline and social networking interventions for the treatment of depression in young people: a systematic reviewSequential treatment with fluoxetine and relapse--prevention CBT to improve outcomes in pediatric depressionOutpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data.Is there a gap between recommended and 'real world' practice in the management of depression in young people? A medical file audit of practiceAntidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study.Pediatric depression: an evidence-based update on treatment interventionsA comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.
P2860
Q24187748-8B7EF056-1631-4DC8-A671-5E542E751754Q24197563-53CCA1FB-53C1-42F9-8827-216AF9573356Q24202831-29E95AD1-3CC6-42A4-80C2-73D97ED76007Q26765149-10C2A19B-D525-412B-84C0-8CCA4CF15BE7Q26824846-A5EB5678-177E-4F8F-93F3-7912E776A8AEQ26850357-C197298E-BF69-4716-BBAC-9773A32F8AE4Q26865021-220CE529-8E1C-471B-A3AF-DB1B8429560CQ27021667-080F4942-C149-441F-8C3F-6242003A2CBBQ28081645-DD350745-6CC9-43FB-A26C-68FE70BE47EFQ28240200-951A1F66-03DD-4927-B866-A191B945330DQ28262885-3259DDBA-4669-4B64-84E2-C751F9A93E5CQ28396360-E73C8178-DADB-4F12-B890-AD75EB4E8BC6Q30472596-73392ADE-1C0A-441F-9DA1-D80463687D82Q30558011-C9984D47-7B21-4786-AD58-000EF9F2F47FQ30698395-B8DD5E8B-709A-47EA-9FB5-1A1E679EFE05Q33561411-B4B2E91D-7DF4-47D1-96A0-6D6E08C4600FQ33632399-D880EAA4-1D7B-425F-A8B7-F2C23CE68880Q33639080-9ECA55BD-76BD-4E43-BA66-4F6F126F647FQ33655082-73BEB46A-C35A-440B-96C9-1205182B9F69Q33667966-290F45D4-F1D0-4BDA-BDB7-5861DDD6F66CQ33770101-C1B84965-A37F-4B4A-8C9B-576E39CE40D6Q33783427-DD919A78-581F-436F-9BA4-9ECE6846DE34Q33819692-13BBE5BA-24DB-4248-92F0-C97D177CDF45Q33861523-902A6A3B-0570-4305-B751-1965DFA8021BQ33867586-34BAA2D8-0A5E-4112-B33B-CE7EBF94D875Q33914536-ABE6D3AC-F813-4EEA-BB3E-85E949533981Q33919579-7831837F-5084-4E2A-A458-CD6DFA614237Q33927517-2C388742-895F-454F-B29E-AB050E6DEFD3Q33986114-08679E67-C46F-43ED-A438-2BF94BA38EB1Q34085473-A61764E1-6F0C-4042-9962-BBE1C8F34F49Q34124607-FCDDBC8B-9811-4752-B371-5B6765081682Q34127450-E744F1B4-F222-40D0-A38D-3030AE135A4DQ34218921-7104B09D-9322-4BC9-9C4B-EA5171B41878Q34268436-B2D488EE-8EBD-4730-B423-BC4105EF5167Q34276033-3D7C0948-C347-4AAE-8BCA-1389B7C6CA29Q34283902-0396C77F-D7DA-46FA-B068-742F8B28ED9FQ34318917-ABD5A350-51D9-49CF-BEAC-86F80D16F4FEQ34330685-9849CBB9-28A0-48A8-8A6A-A5DABDD197BAQ34359585-A262C442-0895-4FD5-8BC4-D1F082FFD020Q34399261-678AFDA9-C11B-44B0-B960-8EF5F28798C2
P2860
Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Practice parameter for the ass ...... nts with depressive disorders.
@ast
Practice parameter for the ass ...... nts with depressive disorders.
@en
Practice parameter for the ass ...... nts with depressive disorders.
@nl
type
label
Practice parameter for the ass ...... nts with depressive disorders.
@ast
Practice parameter for the ass ...... nts with depressive disorders.
@en
Practice parameter for the ass ...... nts with depressive disorders.
@nl
prefLabel
Practice parameter for the ass ...... nts with depressive disorders.
@ast
Practice parameter for the ass ...... nts with depressive disorders.
@en
Practice parameter for the ass ...... nts with depressive disorders.
@nl
P2093
P1476
Practice parameter for the ass ...... nts with depressive disorders.
@en
P2093
AACAP Work Group on Quality Issues
Allan Chrisman
David Brent
Heather Walter
Helene Keable
Jennifer Medicus
Joan Kinlan
John Hamilton
Kristin Kroeger Ptakowski
Laurence Greenhill
P304
P356
10.1097/CHI.0B013E318145AE1C
P577
2007-11-01T00:00:00Z